Academic Journals Database
Disseminating quality controlled scientific knowledge

Comparing Therapeutic Effects of Reboxetine with Placebo in Adult Patients with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled Clinical Trial

ADD TO MY LIST
 
Author(s): Forogh Riahi | Zahra Shahrivar | Mehdi Tehrani Doost

Journal: Scientific Medical Journal
ISSN 1026-8960

Volume: 9;
Issue: 5;
Start page: 483;
Date: 2010;
Original page

Keywords: Attention-Deficit/Hyperactivity Disorder | Reboxetine | Conner's ADHD Rating Scale

ABSTRACT
Background and Objective: Attention-deficit-hyperactivity disorder (ADHD) in adults is accompanied with different complications such as decreased occupational and educational performance. At present, stimulant drugs are used as the first line treatment in this disorder. However, possible development of side effects and dependence on these drugs are of concern. Therefore, it was decided to evaluate the efficacy of reboxetine in the treatment of adults with attention-deficit-hyperactivity disorder. Subjects and Methods: Forty adult diagnosed with ADHD without any significant psychiatric disorder were participated in a 6-weeks a double blind clinical trial with reboxetine (8 mg/d) in two divided doses. The principle measured outcome was the Conner's ADHD Rating Scale (adult version). Results: Rate of response (decrease of Conner’s rating scale scores) in reboxetine group were significantly greater than control group (p
Why do you need a reservation system?      Affiliate Program